SAN DIEGO, Feb. 04, 2016 (GLOBE NEWSWIRE) — Medical Marijuana, Inc.’s (OTC Pink:MJNA) is proud to inform shareholders and the public that Reuters wire news agency featured the Company in the article California-based Medical Marijuana Eyes Mexico as Next Big Market. In an historic move, the government of Mexico issued two of the country’s first permits to import a cannabidiol product, RSHO-X, from the U.S. headquartered industrial hemp company.
“With Mexico’s government’s decision to approve import permits, we are extremely proud of our capability to provide our cannabidiol (CBD) hemp oil, RSHO-X, to the more than 120 million residents of Mexico,” states Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. “Our overall mission is ‘access for all’ and this is a major milestone achievement.”
According to the Reuters report, imports to Mexico are “restricted to products free of tetrahydrocannabinol (THC), the ingredient in marijuana that gets you ‘high’.” RSHO-X contains cannabidiol, the non-psychoactive component of the hemp plant.
Reuters continues, “With a population of 120 million people, Mexico could eventually provide a sizeable market for marijuana investors.” The report estimates the market in Mexico for cannabidiol (CBD) hemp oil to be $1-2 billion over ten years.
Additional reports include Fortune and Business Insider. Details of the COFEPRIS announcement can be found here: http://www.cofepris.gob.mx/Documents/NotasPrincipales/01022016.pdf
Additional information is listed on the HempMeds® Mexico website. For more information on RSHO-X, visit http://www.hempmeds.mx
About HempMeds® Mexico
HempMeds® Mexico is a Mexico-based company, created to provide access to cannabinoid-based products including cannabidiol (CBD) hemp oil products as they become legal in the country of Mexico for the first time. Our Company is a sales, marketing and distribution company. HempMeds® Mexico plans to work directly with the Mexican government to safely and legally provide access to our CBD hemp oil products. HempMeds® Mexico is the first company to legally ship RSHO-X CBD hemp oil into Mexico. For more information, please review the company’s website at: http://hempmeds.mx/.
HempMeds® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds® is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana Inc.
The mission of Medical Marijuana, Inc. (OTC Pink:MJNA) is to be the premier hemp industry innovator, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.